Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1321325

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1321325

Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Biopharmaceutical 3PL Market Growth & Trends

The global biopharmaceutical third-party logistics (3PL) market size is expected to reach USD 198.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2023 to 2030. Increasing demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the market growth. The rising adoption of automated storage and retrieval systems in emerging countries is an ongoing trend among pharmaceutical logistics companies that has gained significant traction.

Furthermore, the trend of shifting from small-molecule drugs to biopharmaceuticals, mainly vaccines and biologics, is projected to drive the market. Since, these small molecule drugs are temperature-sensitive products, demand for temperature-controlled transportation and storage increases and thus, is responsible for the market growth. Technological advancements are among the main factors drivingmarket growth. Technologies, such as mobile cloud solutions, warehouse robotics, and data mining, have changed the overall 3PL space. With the help of these advanced technologies, 3PL companies can maintain the required temperatures for products during transportation.

This will help in reducing complexities in products and human errors. Most biopharmaceutical products are very temperature-sensitive and hence should be stored at the required temperatures. These products require a tracking device for monitoring until delivery. For instance, in May 2023, Tridentify launched a real-time cold chain monitoring system with an innovative feature for continuously tracking the stability and remaining shelf life of products transported in the cold chain. It offers a thorough view of the stability and remaining shelf-life of pharmaceutical products in real-time, which will revolutionize the way companies monitor their operations and manage their stability budgets.

In addition, environmental concerns and costs have caused a slight shift in the means of transport used for commercial products, moving from airway to seaway shipping and in roadways from truck to intermodal (both rail and truck) transport. Intermodal transport is majorly used by these pharmaceutical companies to reduce their carbon footprint. The ongoing trend shows that pharmaceutical manufacturers have shifted to sea freight to reduce the cost and risk factors. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.

Biopharmaceutical 3PL Market Report Highlights

  • In 2022, the non-cold chain logistics segment held the largest share of 79.7% in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control
  • The cold chain logistics segment is expected to register a CAGR of 8.8% over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
  • The warehousing and storage segment held the largest share of 43.3% in 2022. The transportation segment also held a significant revenue share in 2022 due to the lack of internal capabilities of companies
  • North America held the largest revenue share of over 42% in 2022 owing to the rise in imports and exports for biopharmaceutical in the country
  • Asia Pacific is expected to register the fastest CAGR of 7.4% over the forecast period owing to the adoption of medicines from the aging population and the shift of drug sales from brand manufacturers to generic
  • The key players are undertaking several strategic initiatives to strengthen their market presence. For instance, in February 2021, Kuehne+Nagel entered into a partnership with China's largest non-state-owned pharma distribution company, Jointown, to enhance its footprint in healthcare & pharmaceutical logistics in China
Product Code: GVR-2-68038-773-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. Methodology
  • 1.5. Research Scope and Assumptions
  • 1.6. Market Formulation & Validation
    • 1.6.1. COUNTRY MARKET: CAGR CALCULATION
  • 1.7. Country Based Segment Share Calculation
  • 1.8. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional Insights
  • 2.4. Competitive Insights
  • 2.5. Biopharmaceutical Third Party Logistics Market Snapshot
  • 2.6. Biopharmaceutical Third Party Logistics Market Segment Snapshot
  • 2.7. Biopharmaceutical Third Party Logistics Market Competitive Landscape Snapshot

Chapter 3. Biopharmaceutical Third Party Logistics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Biopharmaceutical Third-party Logistics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Biopharmaceutical Third-party Logistics Market: Service Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biopharmaceutical Third-party Logistics Market: Service Movement Analysis, USD Billion, 2022 & 2030
  • 4.3. Transportation
    • 4.3.1. Transportation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.2. Air Freight
      • 4.3.2.1. Air Freight Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.3. Sea Freight
      • 4.3.3.1. Sea Freight Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.4. Overland Transportation
      • 4.3.4.1. Overland Transportation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Warehousing & Storage
    • 4.4.1. Warehousing & Storage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Others
    • 4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Biopharmaceutical Third Party Logistics Market: Supply Chain Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biopharmaceutical Third Party Logistics Market: Supply Chain Movement Analysis, USD Billion, 2022 & 2030
  • 5.3. Cold Chain
    • 5.3.1. Cold Chain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Non-Cold Chain
    • 5.4.1. Non-Cold Chain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Biopharmaceutical Third Party Logistics Market: Regional Estimates & Trend Analysis

  • 6.1. Biopharmaceutical Third Party Logistics Market: Regional Movement Analysis, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. Regulatory Framework
    • 6.2.3. U.S.
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. U.S. Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.4. Canada
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Canada Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.2. Regulatory Framework
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. UK Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.4. Germany
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Germany Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.5. France
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. France Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.6. Italy
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Italy Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.7. Spain
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Spain Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.8. Denmark
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Denmark Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.9. Sweden
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Sweden Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.10. Norway
      • 6.3.10.1. Key Country Dynamics
      • 6.3.10.2. Competitive Scenario
      • 6.3.10.3. Norway Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. Regulatory Framework
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Japan Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. China
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. China Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.5. India
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. India Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Australia Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Thailand Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.8. South Korea
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. South Korea Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Regulatory Framework
    • 6.5.3. Brazil
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Brazil Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Mexico Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Argentina
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Argentina Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Middle East & Africa
    • 6.6.1. Middle East & Africa Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Regulatory Framework
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. South Africa Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. Saudi Arabia
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Saudi Arabia Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. UAE
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. UAE Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Kuwait
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Kuwait Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Company Market Share Analysis, 2022
  • 7.3. List of Key Private Players
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. DHL International GmbH
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. SF Express
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. United Parcel Service of America, Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. AmerisourceBergen Corp.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. DB Schenker
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Kuehne and Nagel
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Kerry Logistics Network Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Agility
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
Product Code: GVR-2-68038-773-5

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 4. Global Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 5. Global Biopharmaceutical Third-party Logistics Market by Region, 2018 - 2030 (USD Billion)
  • Table 6. North America Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 7. North America Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 8. North America Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 9. U.S. Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 10. U.S. Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 11. Canada Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 12. Canada Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 13. Europe Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 14. Europe Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 15. Europe Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 16. Germany Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 17. Germany Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 18. UK Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 19. UK Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 20. France Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 21. France Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 22. Italy Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 23. Italy Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 24. Spain Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 25. Spain Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 26. Denmark Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 27. Denmark Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 28. Sweden Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 29. Sweden Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 30. Norway Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 31. Norway Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 32. Asia Pacific Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 33. Asia Pacific Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 34. Asia Pacific Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 35. China Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 36. China Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 37. Japan Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 38. Japan Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 39. India Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 40. India Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 41. South Korea Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 42. South Korea Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 43. Australia Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 44. Australia Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 45. ThailandBiopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 46. ThailandBiopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 47. Latin America Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 48. Latin America Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 49. Latin America Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 50. Brazil Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 51. Brazil Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 52. Mexico Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 53. Mexico Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 54. Argentina Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 55. Argentina Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 56. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 57. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 58. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 59. South Africa Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 60. South Africa Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 61. Saudi Arabia Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 62. Saudi Arabia Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 63. UAE Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 64. UAE Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 65. Kuwait Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 66. Kuwait Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Primary Research Pattern
  • Fig. 2 Market Research Approaches
  • Fig. 3 Value Chain-Based Sizing & Forecasting
  • Fig. 4 Market Formulation & Validation
  • Fig. 5 Biopharmaceutical Third-party Logistics Market, Market Segmentation
  • Fig. 6 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 7 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 9 Penetration & Growth Prospect Mapping
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Biopharmaceutical Third-party Logistics Market for Cold chain, 2018 - 2030 (USD Billion)
  • Fig. 15 Global Biopharmaceutical Third-party Logistics Market for Non-cold chain, 2018 - 2030 (USD Billion)
  • Fig. 16 Global Biopharmaceutical Third-party Logistics Market for Transportation, 2018 - 2030 (USD Billion)
  • Fig. 17 Global Biopharmaceutical Third-party Logistics Market for Air freight, 2018 - 2030 (USD Billion)
  • Fig. 18 Global Biopharmaceutical Third-party Logistics Market for Sea freight, 2018 - 2030 (USD Billion)
  • Fig. 19 Global Biopharmaceutical Third-party Logistics Market for Overland transportation, 2018 - 2030 (USD Billion)
  • Fig. 20 Global Biopharmaceutical Third-party Logistics Market for Warehousing and storage, 2018 - 2030 (USD Billion)
  • Fig. 21 Global Biopharmaceutical Third-party Logistics Market for Others, 2018 - 2030 (USD Billion)
  • Fig. 22 Regional Outlook, 2021 & 2030
  • Fig. 23 North America Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 24 U.S. Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 25 Canada Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 26 Europe Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 27 Germany Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 28 UK Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 29 France Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 30 Italy Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 31 Spain Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 32 Denmark Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 33 Sweden Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 34 Norway Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 35 Asia Pacific Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 36 Japan Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 37 China Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 38 India Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 39 Australia Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 40 South Korea Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 41 Thailand Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Latin America Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 43 Brazil Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Mexico Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Argentina Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 46 Middle East and Africa Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 47 South Africa Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Saudi Arabia Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 49 UAE Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Kuwait Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!